(Purpose) Post-operative recurrences are major determinants of survival for patients who have undergone curative resection of hepatocellular carcinoma. If the recurrent tumors located in segment VII and VIII or extrahepatic location, such as a subdiaphragm, a transthoracic transdiaphragmatic approach via thoracoscopy is feasible. Since the technique has the advantage of better intrathoracic exposure avoiding severe adhesiolysis, liver mobilization and possible hepatic congestion. We report a case of extrahepatic metastatic hepatocellular carcinoma that was successfully resected by transthoracic thoracoscopic metastasectomy. (Methods) A 68-year-old male patient who has undergone posterior sectinectomy with caudate lobectomy (S1,6,7) and cholecystectomy under a diagnosis of hepatocellular carcinoma at 3 years ago, was admitted to our hospital for further evaluation of extrahepatic metastatic tumor in right subphrenic space during the routine check-up. On liver dynamic computed tomography revealed a well-defined mass of 3.5 cm in diameter, in right subphrenic space with invading diaphragm and rt. adrenal gland. The imaging findings suggested an extrahepatic hepatocellular carcinoma that metastasized to the diaphragm. LFT was normal and AFP revealed 94.14 ng/ml. (Results) We performed transthoracic thoracoscopic metastasectomy for subdiaphragmatic metastases of HCC and partial diaphragmatic resection and repair. The operation time was 3 hour 30 minutes and blood loss was 100 ml. The patient started a diet POD 1 day and discharged POD 11days due to chest tube. The postoperative course was uneventful, and the patient was discharged without any complications. (Conclusion) Transthoracic thoracoscopic metastasectomy can be feasible even if the recurrent tumors located in segments VII and VIII or extrahepatic location, such as a diaphragm.
(Purpose) Post-operative recurrences are major determinants of survival for patients who have undergone curative resection of hepatocellular carcinoma. If the recurrent tumors located in segment VII and VIII or extrahepatic location, such as a subdiaphragm, a transthoracic transdiaphragmatic approach via thoracoscopy is feasible. Since the technique has the advantage of better intrathoracic exposure avoiding severe adhesiolysis, liver mobilization and possible hepatic congestion. We report a case of extrahepatic metastatic hepatocellular carcinoma that was successfully resected by transthoracic thoracoscopic metastasectomy. (Methods) A 68-year-old male patient who has undergone posterior sectinectomy with caudate lobectomy (S1,6,7) and cholecystectomy under a diagnosis of hepatocellular carcinoma at 3 years ago, was admitted to our hospital for further evaluation of extrahepatic metastatic tumor in right subphrenic space during the routine check-up. On liver dynamic computed tomography revealed a well-defined mass of 3.5 cm in diameter, in right subphrenic space with invading diaphragm and rt. adrenal gland. The imaging findings suggested an extrahepatic hepatocellular carcinoma that metastasized to the diaphragm. LFT was normal and AFP revealed 94.14 ng/ml. (Results) We performed transthoracic thoracoscopic metastasectomy for subdiaphragmatic metastases of HCC and partial diaphragmatic resection and repair. The operation time was 3 hour 30 minutes and blood loss was 100 ml. The patient started a diet POD 1 day and discharged POD 11days due to chest tube. The postoperative course was uneventful, and the patient was discharged without any complications. (Conclusion) Transthoracic thoracoscopic metastasectomy can be feasible even if the recurrent tumors located in segments VII and VIII or extrahepatic location, such as a diaphragm.
KAHBPS-P-02
Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma Department of Surgery, Ajou University College of Medicine, Korea
Weiguang Xu, Hee-Jung Wang* (Purpose) Since TACE induces hypoxic necrosis in tumors, hypoxia-inducible factor 1α (HIF-1α ) could critically affect biology in residual tumors after TACE treatment and subsequent prognosis. However, HIF-1α and its prognostic relevance in TACE have rarely been examined in human specimens (Methods) In the current study, we investigated the prognosis and expression of genes regulated by HIF-1α in HCC patients receiving preoperative TACE for the first time. In total, 35 patients with HCC (10 patients undergoing preoperative TACE) were retrospectively studied. The prognostic significance of TACE was analyzed using Kaplan-Meier and Cox regression models. Protein levels of HIF-1α and mRNA levels of HIF-1 α -associated genes were examined using im-F51 munohistochemistry (IHC) and real-time RT-PCR, respectively. (Results) Preoperative TACE was significantly associated with increased 2-year recurrence rate (80 vs. 36%, P=0.00402) and shorter disease-free survival (DFS) time (11.9 vs. 35.7 months, p=0.0182). TACE was an independent prognostic factor for recurrence (p=0.007) and poor DFS (p=0.010) in a multivariate analysis. (Conclusion) Our findings collectively demonstrate that preoperative TACE confers poor prognosis in HCC patients through activation of HIF-1α .
(Purpose) microRNAs (miRNAs) are endogenous non-coding 21-23 nucleotide RNAs that are involved in post-transcriptional regulation and they control various cellular processes, one of which is tumorigenesis. miRNAs were reported to be implicated in the pathogenesis of hepatocellular carcinoma (HCC) and the aim of this study is to evaluate the role of miRNAs in the development of HCC. (Methods) To find yet-to-be-identified miRNAs associated with HCC tumorigenesis, we carried out miRNA microarray analysis with miRNAs extracted from normal and HCC liver tissues resected from the same patients. Of the miRNAs showing significantly different expression levels between normal and HCC liver tissues, we focused on miR-128. The difference in expression levels of miR-128 was verified by real-time PCR. In addition, the target gene of miR-128, axin1, was determined by bioinformatics study, luciferase assay and Western blotting (Results) Four pairs of liver tissues were selected for RNA extraction. miRNA microarray and FDR calculation were performed and four genes were selected due to the previous report on their correlation with HCC. The results of luciferase assay and transfection of HepG2 cells indicated that miRNA-128 indeed binds to the 3' UTR of Axin1. In Western blotting study miR-128 indeed decreased Axin1 protein levels, demonstrating that Axin1 is indeed a target of miR-128 in HepG2 cells. (Conclusion) In this study we report that miR-128 is up-regualted in clinical HCC tissues and that miR-128 binds to 3' UTR of Axin1. The identification of miR-128 as oncomir and determination of its target gene Axin 1 will shed light on the pathogenesis of HCC.
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AEG-1 in patients with hepatocellular carcinoma (HCC). (Methods) Eighty-five samples were collected from patients with HCC who underwent surgery and were histopathologically confirmed to have HCC. Two independent pathologists, experienced in evaluating immunohistochemistry and blinded to the clinical outcomes of the patients, reviewed all samples. They determined AEG-1 expression semiquantitatively by assessing the percentage of positively stained immunoreactive cells and staining intensity. Clinicopathological data were analyzed in association with prognosis.
(Results) The association was estimated by univariate and multivariate analyses with Cox regression. Tumor size [hazard ratio (HR), 2.285; 95% confidence interval (CI), 1.175-4.447; p=0.0149], microvascular invasion (HR, 6.754; 95% CI, 1.631-27.965; p=0.0084), and AEG-1 expression (HR, 4.756; 95% CI, 1.697-13.329; p=0.0030) were independent prognostic factors for overall survival. Those for disease free survival rate were tumor size (HR, 2.245; 95% CI, 1.282-3.933; p=0.0046) and AEG-1 expression (HR, 1.916; 95% CI, 1.035-3.545; p=0.038). The cumulative 5-year survival and recurrence rates were 89.2% and 50.0% in the low-expressing group and 24.5% and 82.4% in the high-expressing group, respectively. (Conclusion) The results suggest that AEG-1 overexpression could serve as a valuable prognostic marker in patients with HCC.
KAHBPS-P-05
How to treat liver metastases from breast cancer in surgical aspect 
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BRLM is still controversial and needs further evaluation (Neo-adjuvant, adjuvant, concurrent hormonal therapy).
KAHBPS-P-06
Short-term outcome of laparoscopic radiofrequency ablation for hepatocelluar carcinoma in liver cirrhosis :
The safety and efficacy Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea Byung Gon Na, Gyu Sung Choi, Jong Man Kim*, Choon Hyuck David Kwon, Jae-Won Joh, Jae Berm Park, Sung Joo Kim (Purpose) Radiofrequency ablation (RFA) has been a legitimate treatment for primary and metastatic hepatocellular carcinoma (HCC) with liver cirrhosis. The laparoscopic RFA has replaced percutaneous RFA for HCCs because of poor sonic window, adjacent organ and major vessels. The aims of this study is to assess the clinical data and short-term outcome to evaluate efficacy and safety of laparoscopic RFA for HCCs with cirrhosis. (Methods) Between September 2009 to August 2014, 45 consecutive HCC patients with cirrhosis were treated by laparoscopic RFA. Most patients had hepatitis B (60%) and Child-Pugh class B status (90%). Median age was 60 years (range, 49-84). The short-term outcome was evaluated by radiologic images in 3-, 6-, and 9 months. (Results) Laparoscopic RFA was done in all patients and 49 HCC nodules was completely ablated. There was no procedure related morbidity and mortality. The HCC nodules consisted of primary (n=22), recurred (n=19) and metastatic lesions (n=8). Median nodule diameter was 17 mm (range, 8-40) . The 19 (45%) nodules were located in segment 8. Median time of RFA was 14 minutes (range, 7-28), while total operative time was 130 minutes (range, 63-303) . The combined procedure were adhesiolysis (n=17), cholecystectomy (n=2), colorectal surgery (n=1). The hospital stay was 5 days (range, 3-22) . The 3-, 6-, and 9-months disease-free survival rate was 97.2%, 83.2%, and 78.6% respectively. (Conclusion) Laparoscopic RFA is a safe and effective therapeutic option for HCCs infeasible to percutaneous RFA in patients with cirrhosis. It is suggested that the laparoscopic RFA has the advantage of clinical outcomes comparable to those percutaneous RFA.
KAHBPS-P-07
An initial experience of the upper midline incision for various liver resections in a low volume center 
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tions of patient with malignancies should be performed in order to gain the best possible survival outcome for the patient.
KAHBPS-P-10
A case of leiomyosarcom of the inferior vena cava 
KAHBPS-P-11
A solitary giant hepatic lymphangioma Hwanhyo Lee*, Seonyoul Lee 1 (Purpose) A hepatic lymphangioma is a rare benign neoplasm that is usually associated with a part of systemic lymphangiomatosis. A solitary hepatic lymphangioma is extremely rare. The prognosis of hepatic lymphangioma is good and patients have no need for further treatment after surgical resection. Therefore, we present a rare case of a female patient who underwent right hepatectomy of a solitary giant hepatic lymphangioma. (Methods) A 42-year-old female presented to the emergency department complaining of severe abdominal pain of the right upper quadrant for 1 day. She had no history of abdominal surgery or other medical history. A physical examination revealed a huge, palpable mass occupying the right region of the abdomen. Abdominal computed tomography and sonography showed a 23×30 cm sized, giant, relatively well-defined, homogenous cystic mass with few septa occupying the right liver (Couninaud segments VII,VIII) and extending from the diaphragm to the right iliac crest. Serum CA19-9 was 0.6 U/ml. ICG15 was 25.6%. The preoperative diagnosis was a giant hepatic cystadenoma or cystadenocarcinoma. (Results) At laparotomy, a giant, cystic and tense mass was found at the right bisegments of the liver (Cauinaud VII, VIII), accompanied with minimal spillage of old bloody fluid through the small tearing of a thinned cystic wall. We aspirated about 3,500 ml volume of cystic fluid and performed right hepatectomy and cholecystectomy. The cystic fluid level of CA 19-9 was 0.6 U/ml. Gross pathology revealed a 23×30 cm sized mass with an unilocular cyst and a pink-
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ish white smooth inner surface, which was filled with coffeelike fluid and sludge. Histopathologically, the cystic wall was composed of endothelial cells, that were positive for CD34 on immunohistochemical staining. These findings confirmed the diagnosis of a solitary hepatic lymphangioma. Postoperatively, the patient had an uneventful recovery. She was discharged on postoperative day 10. (Conclusion) Although the prognosis of solitary hepatic lymphangioma is good after surgical resection, the recurrence was reported. Therefore, I consider the patient should be follow-up after operation. Abdominal computed tomography showed hepatomegaly and ascites, and gastrointestinal endoscopy showed esophageal varices. Three main hepatic veins were occluded with complete occlusion of the suprahepatic IVC, thus hepatic venous blood flow was drained into the inferior hepatic veins through the intrahepatic collaterals and passed through the cutaneous venous collaterals. With progression of liver cirrhosis and deterioration of liver function, she was enrolled for liver transplantation, but there was no living donor and very low possibility of deceased organ allocation. Instead of liver transplantation, she underwent endovascular stenting of the IVC for palliation. Septoplasty needle was passed the occluded IVC through internal jugular vein access and then captures from the femoral vein access using a snare wire. After balloon dilatation, severe elastic recoling (>90%) was observed, thus 28x80 mm stenting was done across the occlusion and repeat double ballooning was performed. Final venogram shows restored IVC inflow. Since one day after stenting, she has begun to lose body weight and edematous figure disappeared within 1 week. Her liver function also recovered slowly over several weeks. At 3 months after stenting, she is doing well with nearly normal liver function and marked resolution of cutaneous venous engorgement.
KAHBPS-P-12
(Conclusion) Endovascular IVC stenting appears to be an effective treatment for prevent BCS-associated complications, thus IVC stenting would be performed before marked stenosis or complete occlusion of the IVC.
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KAHBPS-P-13
Efficacy By literature review, we developed several activities and selected 5 monitoring indicators such as performance rate and appropriateness of hand washing, performance rate of contact precaution, acquisition rate and CP (Colonization Pressure) of MDROs in 50-patients general ward setting for 7 months (APR. 2013~OCT. 2013). We educated reducing infection of MDROs, proper hand washing and contact precaution for medical staffs, patients and their families. For environmental management, we regularly changed and cleansed drain cups and bags, also checked disinfection of MDROs patients' environment by using checklists. To monitor 5 indicators, we implemented blind monitoring of medical staffs and calculated acquisition rate and CP of MDROs every month with office of infection control. (Results) We monitored 100 cases of hand washing, 58 cases of contact precaution, 788 patients for acquisition rate and 10,203 days for CP of MDROs. Performance rate of hand washing was 100% that had increased compared to that of 2012, 91.9%. Performance of hand washing in case of "After contact with patient's environment" was 100% of index to rise and appropriateness of hand washing in 2013 was 20.9% that was increased from 2012. The performance rate of contact precaution went beyond 70% in most of items and the performance of "pre-contact hand washing" and "post-contact hand washing" of medical department was up 16.7% to 66.7%. The acquisition rate of MDROs was remarkably decreased compared to 2012 (CRAB 2.54% → 1.78%, CRPA 1.55% → 0.76%, MRSA 3.44% → 1.27%, CRE 0.82% → 0.25%, VRE 0.48% → 0.25%). The CP of MDROs was also declined to 2012 (MRSA 4.52% → 3.74%, VRE 0.71% → 0.38%).
(Conclusion) By improving hand washing, contact precaution and environmental management, the acquisition rate and CP of MDROs were effectively controlled. We will revise these activities with continuous evaluation and develop blueprints of patients and their families who make an extended stay in hospital infected with MDROs.
KAHBPS-P-14
Long-term outcome of ischemia-type biliary stricture after endoscopic treatment in liver living donors often thin with close approximation of the right hepatic artery (RHA), thus isolation of RHA can result in excessive thinning of the remnant proximal bile duct wall during right liver graft harvest. This injury can induce delayed stricture of the donor common bile duct. This study intended to review the clinical course of such ischemia-type donor bile duct injuries which were primarily managed with endoscopic treatment. (Methods) A retrospective review of medical records was performed with 4 donors who suffered from ischemia-type donor bile duct injury and followed up for more than 5 years.
(Results) A right liver graft was harvested from these 4 donors (incidence of 0.1%), whose mean age was 29.5±3.1 years and all were male. Bile duct anatomy was normal bifurcation in 2 and anomalous branching in 2. All of them recovered from donor surgery and discharged uneventfully, but liver function abnormality and/or subclinical left hepatic duct dilatation was identified 1-2 months after surgery. After imaging study including magnetic resonance cholangiography, they underwent endoscopic balloon dilatation and temporary stent (endoscopic retrograde biliary drainage [ERBD]) insertion. With ERBD tube change per 2 months, ERBD tubes were successfully removed after 4 to 6 month. On yearly follow-up for 5 years, none of these patients showed any evidence of recurrence of biliary stricture. (Conclusion) Based on our experience, endoscopic treatment and subsequent long-term follow-up appears to be an effective and reasonable treatment for ischemia-type biliary stricture in liver living donors.
KAHBPS-P-15
Acute kidney injury after liver transplantation 
25). (Conclusion)
There was a high incidence of AKI in patients undergoing liver transplantation but there were no increased risk of 1 year mortality.
KAHBPS-P-16
Kaposi sarcoma after liver transplantation : Case report Department of Surgery, Pusan National University Yangsan Hospital, Korea
Youngmok Park, Hyunyong Lee, Kwangho Yang, Jeho Ryu, Chongwoo Chu* (Purpose) Kaposi sarcoma is a rare disease in usual circumstance, but in transplantation patient, it is relatively common as a consequence of prolonged immunosuppression. Kaposi sarcoma after transplantation can lead to multifocal, progressive lesion with frequent involvement of the oral mucosa and dissemination to the viscera. It's prevalence depends on the human herpesvirus type 8 (HHV8) infection. Most of posttransplant Kaposi sarcoma occur as a result of viral reactivation. (Methods) report a case of Kaposi sarcoma ocurred after liver transplantation in our institute. (Results) A 50-year-woman underwent deceased donor liver transplantation for Hepatitis B related liver cirrhosis. He was immunosuppressed with tacrolimus and mycophenolate, steroid. Her posttransplant course was uneventful, but she was readmitted on 8th posttransplant month with pancytopenia, elevation of serum creatinin. Multiple lymph node enlargement was seen in neck, chest, abdominal computed tomography (CT) and palpable at physical examination on neck and both inguinal area. Excisional biopsy on inguinal lymph node was done, revealed Kaposi sarcoma without cutaneous lesion. She treated by mTOR inhibitor use, discontinuation of calcineurin inhibitor and conventional medical care. But her progression is poor, after two month, progressive renal and pulmonary insufficiency was occurred. Despite of intensive care, she expired at 11th posttransplant month with multiorgan failure. (Conclusion) After organ transplantation, there are greater risk of Kaposi sarcoma compared with the general population. Visceral Kaposi sarcoma usually appears between 6 and 12 months posttransplant. For patients without cutaneous involvement the diagnosis is difficult. Early diagnosis is important for prognosis, whereas patients who present without treatment show a high mortality.
KAHBPS-P-17
Living donor liver transplantation for diffuse biliary papillomatosis 
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fuse involvement of the biliary system with villotubular adenoma with focal high grade dysplasia. Although there was no evidence of overt adenocarcinoma on endoscopic biopsy, we couldn't be sure that there is no malignant tumor. Because there was diffuse involvement of both the intrahepatic as well as extrahepatic bile ducts with papillomatosis, we decided to perform resection of extrahepatic bile duct in addition to liver transplantation. (Results) We used modified right lobe graft from his son and graft-recipient-weight-ratio was 1.07. Fortunately. intraoperative choledochoscope confirmed the terminal segment of intrapancreatic CBD being free of tumor, so we could avoid pancreaticoduodenectomy. Final biopsy diagnosis was the same as preoperative biopsy result, and distal bile duct margin was tumor negative. After liver transplantation, the patient recovered without any complication and he is doing well without any evidence of recurrence 3 months after the surgery. (Conclusion) We suggest that living donor liver transplantation can be a good therapeutic option for diffuse intraductal papillomatosis. Intraoperative choledochoscope was very helpful in securing the distal margin of the extrahepatic bile duct in papillomatosis.
KAHBPS-P-18
Comparison of open versus laparoscopic operation for T2 gallbladder cancer Our aim was to evaluate and compare the performance of these two models in predicting complication, length of stay (LOS) (Methods) Patients who visited Emergency room and underwent cholecystectomy at our institution between March 2014 and September 2014 were identified. Anatomic, physiologic, and Comorbidity score were determined, squared, and added together to create the SAS-G. The outcomes of extended LOS, complication were recorded. Area under the receiver operating characteristic curve (AUROC) analysis was performed. (Results) There were 79 patients with a mean age of 55 years. All of the cohort underwent laparoscopic cholecystectomy during the index hospital admission. There was an 1.2% complication rate, and an extended LOS (>4 days) rate of 13.9%. There was no mortality. The median anatomic score was 2, physiologic score 0, and comorbidity score 1 for a median SAS-G of 9. AUROC analysis demonstrated that two scoring system have no significant differences in prediction of extended LOS (0.727 vs 0.750) (Conclusion) In our study, complication and mortality rate is much low compare with US group, and we cannot show the superiority of severity score between Anatomic score and SAS-G in prediction of LOS. der cancer are divided into the hilar lymph node,and other regional lymph nodes. This has been reclassified in terms of the possibility of surgical resection and patient outcome. In the 7th edition of TNM staging, N differentiation is probably the most notable point. According to the 7th edition of AJCC TNM staging for GBC, presence of lymph node metastasis makes the stage IIIB (N1) or IVB (N2), which implicates poor prognosis, N1 status becomes the most important prognostic factor with wide coverage of T1-3. However, in practice, we experienced that a considerable proportion of patients with hilar lymph node metastasis showed unusually poor outcomes after curative resection, especially in patients with stage pT3N1M0 (Methods) 103 patients who underwent R0 resection from July 1996 to June 2009 and whose GBC pathology was confined to T3N0, T1-3N1 or T1-3N2 according to the 7th edition of AJCC staging system.). They were simply stratified into 5 groups as T3N0 (n=26),
KAHBPS-P-20
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T1N1 (n=13), T2N1 (n=35), T3N1 (n=20) and TxN2 (n=9). (Results) 5 year survival rates of cancer associated death measured at each overall stage were as follows :60.6% (T3N0), 15.4% (T1N1), 28.6% (T2N1),5.7% (T3N1),22.2% (TxN2). Among the 5 groups, the survival of T3N1 group appeared lowest (5.7%). A greatest survival difference was observed between T3N0 and T3N1 group (P=0.0002). A noticeable survival difference was observed between T2N1 and T3N1 group (P=0.031) and between T1N1 and T3N1 group (P=0.079). In contrast, there was no significant survival difference between TxN2 and T3N1 group (P=0.534). (Conclusion) the prognosis of T3N1 GBC is poor and comparable to that of N2 lesions. Therefore, we suggest that T3N1 GBC be included in stage IV category The purpose of this study is to determine optimal timing for laparoscopic cholecystectomy after PTGBD for acute cholecystitis. (Methods) This retrospective study was conducted on patients who underwent cholecystectomy after PTGBD from January 2012 through June 2014. Forty-five patients were included in this study. And patients were divided into two groups. Group I patients underwent cholecystectomy within 10 days after PTGBD (n=23), whereas group II patients underwent cholecystectomy at more than 10 days after PTGBD (n=22). (Results) There were no significant differences between groups in conversion rate to open surgery, operation time, perioperative complications, and hospital stay after cholecystectomy. But complications related with PTGBD was significantly higher in group II than that in group I (Group I : Group II=0 : 14.6%; p=0.032) (Conclusion) In this study, the timing of laparoscopic cholecystectomy after PTGBD does not influence the rate of conversion to open surgery, operation time, perioperative complications, and hospital stay after cholecystectomy. So the best timing of laparoscopic cholecystectomy after PTGBD be made after considering patient condition, and surgeon's experience. And further prospective studies are required to support these findings. 
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KAHBPS-P-22
KAHBPS-P-23
KAHBPS-P-24
Predictors and patterns of recurrence after resection of intrahepatic cholangiocarcinoma 
KAHBPS-P-26
Risk of development of biliary malignancy after cyst excision for choledochal cyst 
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level of confluence with the pancreatic duct and wide anastomosis with free drainage of bile should be performed. Thereafter, life-long regular follow-up through tumor marker such as serum level of CA19-9 and imaging modalities such as computed tomography or ultrasonography for early detection of subsequent biliary malignancy after cyst excision should be done.
KAHBPS-P-27
Clinical features of the gallbladder adenoma
Department of Surgery, Daegu Fatima Hospital, Korea
Junho Sohn, Jung Ahn Rhee, Jong Hoon Park* (Purpose) GB adenoma is an unusual benign disease of the gallbladder which account for about 5% of all gallbladder polyps. The other gallbladder polyps include cholesterol polyps, adenomyomas, inflammatory polyps, fibromas, leiomyomas and lipomas. Unlike the colon polyps, not the adenoma-carcinoma sequence but the dysplasia-carcinoma pathway appear to be the predominant mechanism of gallbladder cancer. But, recently some studies showed GB adenoma may be precancerous lesion of gallbladder cancer. We investigated our cases of GB adenoma who underwent cholecystectomy for various reasons and analyzed clinical features of the gallbladder adenoma.
(Methods) Among the 3793 patients who underwent cholecystectomy in Daegu Fatima hospital during January 2006 to August 2014, there were 38 patients who were diagnosed with gallbladder adenoma by postoperative pathologic findings. We performed abdominal ultrasound and abdominal CT scan for preoperative evaluation of gallbladder. We reviewed medical records and radiologic images of all patients and histological findings were reviewed by one pathologist. (Results) There were 16 males and 22 females among 38 patients, and the average age of patients was 57.5 years old (30-89yr). 24 patients were diagnosed with GB polyps, 9 patients were diagnosed with GB stones and 4 patients were diagnosed with GB cancer preoperatively. No cases were diagnosed gallbladder adenoma preoperatively. In histological findings, the average size of GB adenomas was 9.0mm (2-35mm), there were 29 cases of tubular adenoma and 7 cases of papillary adenoma and 2 cases of mixed tubular and papillary adenoma. There were 16 cases of GB adenoma accompanied with gallstones and among them, 5 cases were combined acute cholecystitis. There were 3 cases of combined pathology of GB adenoma and cholesterol polyps of gallbladder. We didn't add the cholesterolosis and chronic cholecystitis to combined pathology. (Conclusion) GB adenoma is a rare disease of the gallbladder and it is very difficult to diagnose preoperatively. In our cases there were no cases diagnosed as GB adenoma preoperatively and many cases were diagnosed as GB polyps. The average size of GB adenoma was 9.0mm and minimal size of GB adenoma was only 2mm which didn't meet the indication of cholecystectomy for GB polyps. There was only one case of combined pathology of GB cancer and GB adenoma. Because of lack of prospective studies of GB adenoma, it is necessary to investigate more about these rare diseases.
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the background of IPMN with high grade dysplasia. The length of resection margin from IPMN was 0.5cm. He recovered and was discharged at postoperative 13 days. (Results) A patient was followed up on outpatient deparment for 6 months and any evidence of recurrence was not checked. (Conclusion) In selected patients, complete surgical resection can be performed safely without diminishing QOL, and is associated with long-term survival, and when cystic tumor arising from IPMN-B were suspicious, a complete and aggressive surgical treatment should be planned.
KAHBPS-P-30
Lymphoid hyperplasia arising from bile duct and gallbladder simultaneously mimicking cholangicarcinoma and gallbladder cancer (Purpose) Lymphoid hyperplasia is a rare benign lymphoproliferative disorder. It can occur in various organs. However, lymphoid hyperplasia arising from extrahepatic bile duct and gallbladder simultaneously is extremely rare. (Methods) A 72-year-old woman visited hospital with general weakness, dyspepsia and weight loss for 3 months. She had medical history of diabetes mellitus and depressive mood disorder and had been treated for liver abscess ten years ago. On physical examination, there was no icteric sclera and no tenderness in the upper abdomen. Viral hepatitis markers and all tumor markers were within normal limits. Magnetic resonance cholangiopancreatography (MRCP) showed 3cm length wall thickening and enhancement of suprapancreatic and intrapancreatic CBD, causing mild luminal narrowing and dilatation of upper biliary tract and also showed irregular wall thickening and enhancement of gallbladder body and fundus. (Results) Under diagnosis of distal CBD cancer and gallbladder cancer, she underwent pylorus-preserving pancreaticoduodenectomy with routine lymph node dissection and s4b and S5 liver wedge resection. In operation finding, there were diffuse nodular sclerosing change from mid CBD to distal CBD and there were diffuse wall thickening of gallbladder body at liver bed side. Based on pathologic finding and immunohistochemical staining, lesion was diagnosed histologically as lymphoid hyperplasia (Conclusion) Lymphoid hyperaplasia is a rare disease, and preoperative diagnosis is difficult. Although it is benign condition, we should consider surgical excision for this lesion that cannot be excluded for malignancy.
KAHBPS-P-31
Synchronous double primary squamous cell carcinoma and adenocarcinoma of extrahepatic bile duct: Report of a case 
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mon hepatic duct and at distal common bile duct. Pylorus preserving pancreaticoduodenectomy was done without involvement of resection margin.
(Results) Pathologic findings showed squamous cell carcinoma at proximal lesion and adenocarcinoma at distal lesion. (Conclusion) Three months later, multiple metastatic conglomerated tumors were detected in the liver and the patient died eight months after diagnosis.
KAHBPS-P-32
Tuberculous cholecystitis with cholecysto-colonic fistula : A case report (Purpose) Gallbladder tuberculosis is an extremely rare disease. It can mimic other gallbladder disease, because accurate preoperative diagnosis is difficult and diagnosis is made by histopathologic examination after cholecystectomy (Methods) A 54 year old man was visited our hospital presenting abdominal discomfort. He had medical history of hypertension and diabetes mellitus. He was treated with endoscopic retrograde cholangiopancreatogram for common bile duct stone removal by 6 months ago. He was afebrile, there were tenderness in right upper quadrant area and no Murphy's sign on physical examination. In laboratory findings, complete blood count showed only leukocytosis and other blood chemistries and viral serologic markers were normal. Serum CA 19-9 was elevated. (115.2 U/ml) Abdominal computed tomography (CT) revealed diffuse wall thickening of gallbladder and several gallstones. Based on these findings, preoperative diagnosis was thought be xanthogranulomatous cholecystitis or gallbladder cancer.
(Results) In operative findings, sever adhesion between gallbladder, omentum, common bile duct, and transverse colon was observed and gallbladder was thickened, distended and inflamed. We performed cholecystectomy and transverse colon segmental resection, because there were cholecysto-colonic fistula. There were bloody and necrotic material and several stones in gallbladder. Histopathologic examination revealed epitheloid granulomatous with caseating necrosis and presence of Langerhan's giant cells. Therefore, postoperative diagnosis was revealed tuberculosis of cholecystitis. The patient tolerated the procedure well and was discharge 1 week following surgery without any problems. The patient was started on anti tubercular treatment. (Conclusion) Herein, we present a case of tuberculous cholecystitis with cholecysto-colonic fistula.
KAHBPS-P-33
A case of large cell neuroendocrine carcinoma of intrahepatic bile duct Pathologic report showed malignant pheochronocytoma with capsular invasion, presence of large nests or diffuse growth (in >10% of tumor volume), central tumor necrosis (in the middle of large nests) or confluent necrosis, high cellularity, tumor cell spindling even when focal and profound nuclear pleomorphism. Immunostain) A3: S-100 (+), Synaptophysin (+), ChromograninA (+), CD31 (no vascular invasion), . (Conclusion) So we report a case of malignant pheochromocytoma according to Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) and cell cycle/apoptosis markers can predict patients at risk for recurrence and short literature review.
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ductal papillary mucinous neoplasm (BD-IPMN) of the pancreas is still controversial.In this report we describe minimal resection of the pancreas head, which is a method for the removal of BD-IPMN of the head of the pancreas. (Methods) A multilobular cystic lesion (30mm×30mm) in the head of the pancreas was detected in an symptomatic 71-year-old man who underwent a computed tomography examination. He also had distal common bile duct (CBD) stones. His pancreas did not show dilatation of the main pancreatic duct or mural nodule within the tumor. The tumor marker was ranged within normal level. We decided the operation due to his symptom and tumor size. (Results) The tumor was carefully removed along the border of the cyst and the normal parenchyma, with complete preservation of the main pancreatic duct. For protection of pancreatic duct, we tried to perform pancreatic duct stent through the ampulla during surgery which was not successful. We transected the junction of branch duct from main pancreatic duct, the malignancy was not detected in frozen biopsy of ductal margin. His CBD stones also removed via choledochotomy during operation. A pancreatic fistula was not developed during the postoperative period, but duodenal leakage from the duodenostomy site was developed which was well-controlled by conservative treatment. The final pathologic report revealed the high grade dysplasia with negative margin status. (Conclusion) Minimal resection of BD-IPMN is a technically feasible procedure and this operation represents a minimally invasive alternative to pancreas head resection in benign BD-IPMN.
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Clinical outcome for parenchymasparing pancreatectomy (PSP) in pancreatic benign neoplasm 
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Peng's binding pancreaticogastrostomy, in which the stump of pancreas (pancreatic remnant) is inserted into the posterior gastric wall with only two purse-string sutures. (which do not penetrate the pancreas). (Methods) From October 2011 to October 2013 consecutive 43 cases of PPPD were performed using binding pancreaticogastrostomy in Chungnam National University Hospital. All clinical data was collected prospectively. We analysis the short term outcomes of binding pancreaticogastrostomy by postoperative morbidity, postoperative mortality and pancreatic fistula complications.
(Results) 43 patients were performed pancreaticoduodenectomy and all of them were performed using binding pancreaticogastrostomy. 37 cases were malignant neoplasm and 6 cases were benign tumor (4 case of IPNM, 2 case of benign ampullary tumor). Median operation time was 6.75 hours. And all cases were diet start at POD 2. Median drain remove date was POD 8 and median discharge date was POD 14. The overall morbidity was 53% as 23 cases in 17 patients including 3 case of pancreatic fistula, 5 cases of DGE grade A, 2 case of wound hematoma, 1 case of wound infection, 2 case of ascites, 2 case of Abdominal abscess, 1 case of UGI bleeding, 1 case of not removal of drain, 2 case of diarrhea, 1 case of BST uncontrolled, 1 case of fall out of pancreatic stump, 2 case of chyle drainage. There was 3 case of POPF according to definition by ISGPS grading system (2 cases were grade A, 1 case was grade C). Grade C POPF case was related to fall out of pancreatic stump and it had the result of death. Postoperative mortality was 1 case due to multiple organ failure by complications of fall out of pancreatic stump from pancreaticogastrostomy site. (Conclusion) By early term observation after PPPD, Peng's binding PG might be another option of operation techniques in order to minimize POPF. However, binding PG should be performed carefully because of this operation can be cause serious complications. Especially, it is extremely rare to be pancreatic metastatic carcinoma which was originated from the lung. Therefore, we hereby reported a case of which metastatic pancreatic carcinoma was successfully resected by a surgical intervention so called, laparoscopic RAMPS (Radical antegrade modular pancreatosplenectomy). (Methods) A 55-year-old female with a past medical history of hypertension, diabetes mellitus, and dyslipidemia who has been diagnosed with a lung cancer and undergone left pneumonectomy in Konyang university hospital in December 4th, 2013. During the routine follow-up, chest computed tomography (CT) scan showed a 4.4cm sized malignant mass at the tail of the pancreas was identified, and the mass was also seen in magnetic resonance imaging of the pancreas (MR pancreas). (Results) On admission, she complained nonspecific symptoms. No particular sign was detected on the physical examinations. Only unusual laboratory test result was an elevated level of carcinoembryonic antigen (CEA) (6.84 ng per milliliter). She has undergone laparoscopic RAMPS (Radical antegrade modular pancreatosplenectomy) along with left adrenalectomy. After the surgery, the patient was recovered gradually. On 3rd post-
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operative day, she started the soft diet and stayed in the ward. During the recovery, the patient was consistently complaining about the sharp and stabbed left upper quadrant pain and the pain was aggravated by the diet. On 9th postoperative day, the abdomen computed tomography scan revealed 8.1cm sized fluid collection adjacent to the surgical site. On 22nd postoperative day, the patient complained no other symptoms, and the abdominal pain was subsided completely. In follow up CT, fluid collection size increased to 9.6cm. In order to continuation of her chemotherapy, the patient was transferred out to the department of the oncology. (Conclusion) Laparoscopic RAMPS operation can be feasible and is one of the surgical treatment options for the cancer or mass at the tail of the pancreas despite the minor postoperative complications, such as the abdominal pain or fluid collections.
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Migration of pancreaticojejunostomy stent into intrahepatic duct through choledochojejunostomy site after Whipple's operation stent rarely occurred as post-operative complication after Whipple's procedure. In most cases, migrated stent is located in jejunal lumen and then removed through efferent jejunal loop. But, in this case, we found migrated stent into intra-heptic duct (IHD) through choledocho-jejunostomy (CJ) site with IHD stone. We successfully treated with radiological intervention, so we review these series of process.
(Methods) A 64-years-old male who was diagnosed with ampulla of vater cancer has undergone Whipple's operation (pylorus preserving pancreaticoduodenectomy, PPPD) with short stent inserted at PJ site. The follow up CT scan was done in every 6 month. After 3 years, it is found that PJ stent migrates to IHD (segment 2) and IHD stone is formed. The patient complained no specific symptoms and no abnormal laboratory findings.
(Results) Once we tried to remove stone & stent with radiologic intervention; percutaneous transhepatic biliary drainage (PTBD) insertion and capturing stent & stone by snare, but this procedure was failed. So, these migrated stent and stone were planned to push out into the bowel from biliary tract with Forgaty balloon insertion. After intervention, migrated stent and IHD stone were successfully removed. The patient was discharged without any complications. (Conclusion) A migration of pancreatico-jejunostomy (PJ) stent is uncommon post-operative complication. In this case, migrated stent triggered IHD stone. The radiological intervention is considered one of the useful methods
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Ampulla of vater adenosquamous carcinoma Liquid diet started at postoperative 6 days but delayed because of abdominal pain. Diet was restarted at postoperative 12 days and she recovered successfully. She was discharged at postoperative 14 days. (Results) On final pathology, adenosquamous carcinoma of ampulla of Vater was confirmed. Tumor invaded to pancreas (T3) and lymphatic invasion was not found (N0). Her stage was 2A on AJCC 7th edition. (Conclusion) Adenosquamous carcinoma of ampulla of Vater was an extremely rare disease and its progrnosis was not confirmed. In future, this disease should be investigated and understood.
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Pancreas carcinosarcoma :
A case report A 25-year-old female, without known past disease history, had a history of back pain that began 3 years ago and was controlled with NSAIDs prescribed from local orthopedic surgery clinics. Epigastric pain radiating to the back started 6 months ago, and two days before her visit, she was evaluated at a secondary clinic, and was found with a mass located in the pancreas tail on the CT scan, and elevated level of amylase, and lipase. Upon referral to our center, she showed general weakness, weight loss, constipation, diarrhea, epigastric pain, and dyspepsia. Her amylase and lipase were 208 U/L and 261 U/L, respectively. Other laboratory results, including tumor markers, fell within the normal range.
(Results) Abdomen CT scan and MRCP showed a 4.8cm sized mass lesion in the pancreas tail with internal hemorrhage and necrosis. Obstructed splenic vein, due to tumor invasion, was seen, causing a gastric fundal varix. PET-CT showed an intense hypermetabolic mass lesion in pancreatic tail portion
